Evestra, Inc.
Evestra's mission is to develop and commercialize novel steroid products in female healthcare to treat unmet medical need indications.
- Stage Concept Only
- Industry Biotechnology
- Location San Antonio, TX, USA
- Currency USD
- Founded October 2001
- Employees 9
- Website evestra.com
Company Summary
Evestra is a biopharm R&D company conducting research and product development in several needs in the areas of female health (endometriosis, fibroids, fertility control, HRT and hormonal-dependent breast cancer). Novel drug candidates are designed via structure-activity relationship constituting the next generation of steroidal drugs. A 37-yr collaboration with the NIH provides outside validation of Evestra's expertise plus non-dilutive revenue.
Team
-
Ze'ev ShakedPresident & CEO
Extensive managerial and pharmaceutical product development experience in commercializing biologics and conventional drugs includes former President/CEO Spherics; President of ILEX Products and CEO of ILEX Oncology plus a number of senior R&D corporate management postions at ImmuLogic Pharaceutical Corp., Berliex Biosciences, Inc. Triton Biosciences, Inc., CODON Corp. and Chron Corp. PhD in organic and applied biochemistry from MIT.
-
Klaus NickischCSO
More than 28 years of project management and department leadership experience with Schering AG specializing in the areas of chemical development of medicinal applications in oncology and female health. Head of project and portfolio management of the Specialized Therapeutics unit at Berlex. Head of Global Project Management, Berlex. PhD in organic chemistry from the Technical University of Berlin.
-
Maika FriedrichGlobal Project Manager
Advisors
-
Drew Fuller - Hornberger Sheehan Fuller & BeiterLawyerUnconfirmedCarolyne PackeniusAccountantUnconfirmed
Previous Investors
-
Local private investorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.